| The functional role of the ELR motif in CXC chemokine-mediated angiogenesis RM Strieter, PJ Polverini, SL Kunkel, DA Arenberg, MD Burdick, J Kasper, ... Journal of Biological Chemistry 270 (45), 27348-27357, 1995 | 1618 | 1995 |
| CXC chemokines in angiogenesis JA Belperio, MP Keane, DA Arenberg, CL Addison, JE Ehlert, MD Burdick, ... Journal of leukocyte biology 68 (1), 1-8, 2000 | 1086 | 2000 |
| Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines N Ramnath, TJ Dilling, LJ Harris, AW Kim, GC Michaud, AA Balekian, ... Chest 143 (5), e314S-e340S, 2013 | 551 | 2013 |
| Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. DA Arenberg, SL Kunkel, PJ Polverini, M Glass, MD Burdick, RM Strieter The Journal of clinical investigation 97 (12), 2792-2802, 1996 | 519 | 1996 |
| The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. MP Keane, DA Arenberg, JP Lynch 3rd, RI Whyte, MD Iannettoni, ... Journal of Immunology (Baltimore, Md.: 1950) 159 (3), 1437-1443, 1997 | 489 | 1997 |
| Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. DA Arenberg, SL Kunkel, PJ Polverini, SB Morris, MD Burdick, MC Glass, ... The Journal of experimental medicine 184 (3), 981-992, 1996 | 445 | 1996 |
| Final toxicity results of a radiation-dose escalation study in patients with non–small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis FM Kong, JA Hayman, KA Griffith, GP Kalemkerian, D Arenberg, S Lyons, ... International Journal of Radiation Oncology* Biology* Physics 65 (4), 1075-1086, 2006 | 417 | 2006 |
| Interferon γ-inducible protein-10 (IP-10), a member of the CXC chemokine family, is an inhibitor of angiogenesis RM Strieter, SL Kunkel, DA Arenberg, MD Burdick, PJ Polverini Biochemical and biophysical research communications 210 (1), 51-57, 1995 | 415 | 1995 |
| Role of CXC chemokines as regulators of angiogenesis in lung cancer RM Strieter, PJ Polverini, DA Arenberg, A Walz, G Opdenakker, ... Journal of Leucocyte Biology 57 (5), 752-762, 1995 | 356 | 1995 |
| Differential protein expression profiling by iTRAQ− 2DLC− MS/MS of lung Cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype VG Keshamouni, G Michailidis, CS Grasso, S Anthwal, JR Strahler, ... Journal of proteome research 5 (5), 1143-1154, 2006 | 345 | 2006 |
| The role of CXC chemokines as regulators of angiogenesis RM Strieter, PJ Polverini, DA Arenberg, SL Kunkel Shock 4 (3), 155-160, 1995 | 345 | 1995 |
| Electromagnetic navigation bronchoscopy for peripheral pulmonary lesions: one-year results of the prospective, multicenter NAVIGATE study EE Folch, MA Pritchett, MA Nead, MR Bowling, SD Murgu, WS Krimsky, ... Journal of Thoracic Oncology 14 (3), 445-458, 2019 | 342 | 2019 |
| Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. DA Arenberg, MP Keane, B DiGiovine, SL Kunkel, SB Morris, YY Xue, ... The Journal of clinical investigation 102 (3), 465-472, 1998 | 337 | 1998 |
| IFN-γ-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis MP Keane, JA Belperio, DA Arenberg, MD Burdick, ZJ Xu, YY Xue, ... The journal of immunology 163 (10), 5686-5692, 1999 | 332 | 1999 |
| Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis MP Keane, JA Belperio, TA Moore, BB Moore, DA Arenberg, RE Smith, ... The Journal of Immunology 162 (9), 5511-5518, 1999 | 297 | 1999 |
| Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in non-small-cell lung cancer VG Keshamouni, RC Reddy, DA Arenberg, B Joel, VJ Thannickal, ... Oncogene 23 (1), 100-108, 2004 | 273 | 2004 |
| Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. B DiGiovine, JP Lynch 3rd, FJ Martinez, A Flint, RI Whyte, MD Iannettoni, ... Journal of immunology (Baltimore, Md.: 1950) 157 (9), 4194-4202, 1996 | 268 | 1996 |
| Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells BB Moore, DA Arenberg, K Stoy, T Morgan, CL Addison, SB Morris, ... The American journal of pathology 154 (5), 1503-1512, 1999 | 248 | 1999 |
| The IASLC lung cancer staging project: background data and proposed criteria to distinguish separate primary lung cancers from metastatic foci in patients with two lung tumors … FC Detterbeck, WA Franklin, AG Nicholson, N Girard, DA Arenberg, ... Journal of Thoracic Oncology 11 (5), 651-665, 2016 | 244 | 2016 |
| The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer DA Arenberg, PJ Polverini, SL Kunkel, A Shanafelt, J Hesselgesser, ... Journal of leukocyte biology 62 (5), 554-562, 1997 | 238 | 1997 |
Robert M. Strieter, M.D.Strieter ConsultingVerified email at virginia.edu
